This site is intended for Healthcare Professionals only.

DHSC revises concessionary prices for 4 medicines, confirms sufficient stock of Clarithromycin

Date:

Share post:

The improved price for Ezetimibe for the dispensing month of December 2023 is £17.78

The Department of Health and Social Care (DHSC) has redetermined the December 2023 concessionary prices for four medicines following requests made by Community Pharmacy England (CPE) on behalf of community pharmacy owners.

For Ezetimibe 10mg tablets (pack size 28), the price has been fixed at £17.78, up from £9.44.

Other drugs included in the list are Aripiprazole 5mg (£8.52), Digoxin 125microgram (£3.70) and Digoxin 250micrgram (£3.70) tablets.

Contractors would be reimbursed at the new prices only for prescriptions submitted for payment for the dispensing month of December 2023.

CPE said they are still working with DHSC to agree price concessions for January.

Check the final the December 2023 price concessionary here.

Additionally, DHSC on Friday confirmed that there’s now sufficient stock of Clarithromycin 125mg/5ml oral suspension to meet normal demand, and the Serious Shortage Protocol (SSP), SSP053 for the antibiotic expires on 12 January 2024.

Pharmacies are informed that any prescriptions for this medicine must be dispensed in accordance with the prescription as SSP053 will no longer be valid for use.

Clarithromycin is used for the treatment of chest infections such as pneumonia, skin problems such as cellulitis, ear infections, as well to Helicobacter pylori infection.

The drug is only available on prescription, and it comes as tablets, granules, or a liquid that you drink, and can also be given by injection.

Some of the common side effects associated with clarithromycin include feeling sick (nausea) or being sick (vomiting), stomach cramps, and diarrhoea.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Europe Sees Surge in Generic Medicines Withdrawals; UK Faces Doubling of Drug Shortages

Generic medicines for cancer and mental health on the Union List of Critical Medicines are disappearing, study reveals...

NHS to support newly-trained pharmacists with new £1.5 million investment

The new initiative is set to create highly-skilled placement opportunities in community pharmacies, GP surgeries, and care homes...

Professor Mahendra Patel joins UK Pharmacy Professional Leadership Advisory Board

The nine independent expert members of the UK Pharmacy Professional Leadership Advisory Board announced   Professor Mahendra Patel OBE,...

Silent suffering: 12k NHS staff reluctant to share mental health and well-being struggles

Latest UNISON survey underscores mental health absence affecting over 30 per cent of NHS staff including paramedics, and...